Seattle-based KenSci, which helps hospitals predict mortality risk using AI, raises $22M Series B led by Polaris Partners
Transitioning an elderly patient to palliative care can be a difficult decision for caregivers, but it's one that families and clinicians across the globe make every day.
Context & Ripple Effects
KenSci's $22M Series B lands in a Seattle moment: just three months earlier, fellow Seattle startup 98point6 pulled in a $50M Series C led by Goldman Sachs for its virtual primary care app, making the city a repeat stop for large digital-health checks.
Seen against the wider coverage arc, KenSci is an early instance of what became a durable funding lane — AI systems that predict or manage patient outcomes — which later rounds like Sage's $65M Series C for nursing-home distress detection and Courier Health's $50M Series B for biopharma patient-experience management extended into adjacent care settings.
First-order effects
- Polaris Partners' lead gives KenSci fresh capital to push its mortality-risk prediction models deeper into hospital workflows, where clinicians face daily palliative-care transition decisions.
- Hospitals using the platform gain a quantified risk signal on elderly patients at exactly the point where families and caregivers must choose between aggressive treatment and palliative care.
Second-order effects
- The round validates outcome-prediction as an investable healthcare AI category, priming the pipeline of later bets on adjacent settings — nursing homes (Sage), payer/provider administration (Penguin Ai), and biopharma patient journeys (Courier Health).
- Hospital IT buyers now face a widening menu of AI vendors claiming to improve care decisions, forcing procurement teams to weigh competing predictive platforms rather than build internally.
Third-order effects
- If the funding pattern holds, high-stakes care transitions — end-of-life planning chief among them — become increasingly algorithmically mediated, with capital concentrating in startups that own the prediction layer between clinicians and patients.
- A maturing cohort of outcome-AI vendors points toward consolidation pressure in hospital analytics, where point-solution predictors compete to become the default risk-scoring infrastructure inside health systems.
The trend: Venture capital is steadily building a class of AI companies that predict patient outcomes across every care setting — hospitals, nursing homes, payers, and pharma — with KenSci an early hospital-side data point.